Seminar: “Synthetic Essentiality of CHD1 in PTEN-deficient Prostate Cancer”
00-002 Joseph S. Pagano Conference Room, UNC LinebergerDi Zhao, PhD, Odyssey Postdoctoral Fellow, Department of Cancer Biology, UT MD Anderson Cancer Center
Di Zhao, PhD, Odyssey Postdoctoral Fellow, Department of Cancer Biology, UT MD Anderson Cancer Center
Qi-Jing Li, PhD, Associate Professor, Immunology, Department of Immunology, Duke University School of Medicine
Samuel K McBrayer, Postdoctoral Fellow, Department of Medicinal Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Lawrence Fong, MD, Leader, Cancer Immunotherapy Program, Efim Guzik Distinguished Professor in Cancer Biology, Helen Diller Family comprehensive Cancer Center, UCSF
Ben Major, PhD
Smita Bhatia, MD, PhD, Gay and Bew White Endowed Chair in Pediatric Oncology, Professor, Pediatric Oncology, Vice Chair for Outcomes and Survivorship School of Medicine, University of Alabama at Birmingham, Associate Director of Outcomes Research, UAB Comprehensive Cancer Center
Matthew Gamble, PhD, Associate Professor, Department of Pharmacology, Department of Cell Biology, Albert Einstein college of Medicine
Hazem Ghoneim, PhD, St. Jude Children’s Research Hospital